MEGASOFT LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.77 INR | -1.43% |
|
+2.27% | +5.12% |
| Sales 2022 | 524M 6.31M | Sales 2023 | 19.71M 237K | Capitalization | 1.63B 19.61M |
|---|---|---|---|---|---|
| Net income 2022 | 46M 554K | Net income 2023 | 88M 1.06M | EV / Sales 2022 | 7.11 x |
| Net cash position 2022 | 62.1M 748K | Net Debt 2023 | 1.44B 17.28M | EV / Sales 2023 | 155 x |
| P/E ratio 2022 |
69.8
x | P/E ratio 2023 |
18.4
x | Employees | 885 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.46% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.43% | ||
| 1 week | +2.27% | ||
| Current month | -3.74% | ||
| 1 month | -7.36% | ||
| 3 months | -29.76% | ||
| 6 months | +41.12% | ||
| Current year | +5.12% |
1 week
69.23
77.37
1 month
63.6478.12
Current year
56.77107.22
1 year
28.55107.22
3 years
11.25107.22
5 years
4.60107.22
10 years
4.08107.22
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 21-12-09 | |
| Director of Finance/CFO | - | 15-08-10 | |
Srivalli Susarla
CMP | Compliance Officer | - | 18-11-08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anish Mathew
BRD | Director/Board Member | 58 | 09-01-30 |
Krishna Yeachuri
BRD | Director/Board Member | 63 | 22-12-30 |
Leona Ambuja
BRD | Director/Board Member | 37 | 15-03-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 70.77 | -1.43% | 14,155 |
| 24-05-23 | 71.8 | -1.03% | 8,469 |
| 24-05-22 | 72.55 | -4.90% | 56,995 |
| 24-05-21 | 76.29 | +5.00% | 119,354 |
| 24-05-18 | 72.66 | +5.00% | 11,948 |
Delayed Quote Bombay S.E., May 24, 2024 at 06:13 am EDT
More quotes
Megasoft Limited is an India-based company. The Company is focused on pharmaceuticals, defense, manufacturing and others. The Company operates through the pharmaceuticals segment. The Company is engaged in pharmaceutical research and development and in the business of development, production, distribution and sale of chemicals and pharmaceuticals of all kinds has a range of activities aimed at bringing safe, effective and high-quality drugs to the market. It has several products, which include complex oral solid products, complex injectable and drug-device combinations. Its subsidiary is Velapan Systems Private Limited.
Sector
IT Services & Consulting
Calendar
2024-05-28
- Q4 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +5.12% | 62.85M | |
| -14.23% | 189B | |
| +1.48% | 168B | |
| +4.49% | 157B | |
| +6.84% | 102B | |
| +37.66% | 85.01B | |
| +13.18% | 83.75B | |
| -5.04% | 73.04B | |
| -21.53% | 52.32B | |
| -8.25% | 43.86B |
- Stock Market
- Equities
- MEGASOFT Stock
